Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Shinichi Kumon"'
Autor:
Takaaki Wakao, Shinichi Kumon, Hideaki Ishikawa, Daijo Inaguma, Tomomi Kato, Shinichiro Inaba, Seiichi Matsuo, Yukio Yuzawa, Tomonobu Nakamura
Publikováno v:
Nihon Toseki Igakkai Zasshi. 37:1443-1447
73歳男性. 珪肺, 副鼻腔炎手術, 虫垂炎手術の既往あり. 平成14年8月14日より発熱, 倦怠感出現, その後皮膚黄染が出現し, 歩行不能となり当院へ救急搬送された. 来院時より発熱, 無尿, 全身
Autor:
Kazutaka Ito, Yoshio Haruta, Shinichi Kumon, Toshihiko Ichihara, Daijo Inaguma, Nobutaka Kudo, Waichi Sato, Tomomi Maeda, Hirohisa Kato, Satoko Toda, Yutaka Fujita
Publikováno v:
Nihon Toseki Igakkai Zasshi. 30:271-275
安定した血液透析を施行するためには, 良好なブラッドアクセスを維持することが必要である. 最近, PTAをはじめとする各種interventional techniqueが発達し, ブラッドアクセスの長期開存に寄
Autor:
Hidetomo, Nakamoto, Hirokazu, Imai, Hideki, Kawanishi, Masahiko, Nakamoto, Jun, Minakuchi, Shinichi, Kumon, Syuichi, Watanabe, Yoshhiko, Shiohira, Takeo, Ishii, Toshihiko, Kawahara, Hiromichi, Suzuki
Publikováno v:
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis. 22
At the beginning of continuous ambulatory peritoneal dialysis (CAPD), different patients exhibit large differences in peritoneal permeability. To determine if early estimation of peritoneal permeability can predict the prognosis of CAPD, we used data
Autor:
Jun Minakuchi, Takeo Ishii, Hidetomo Nakamoto, Toshihiko Kawahara, Syuichi Watanabe, Hiromichi Suzuki, Shinichi Kumon, Masahiko Nakamoto, Yoshiki Shiohira, Koichi Tsuzaki, Hideki Kawanishi, Hirokazu Imai
Publikováno v:
American journal of kidney diseases : the official journal of the National Kidney Foundation. 40(5)
We evaluated differences in individual peritoneal membrane transport function and nutritional status in patients with diabetes mellitus (DM) and nondiabetic (non-DM) patients on continuous ambulatory peritoneal dialysis (CAPD).We used a newly develop
Autor:
Kazuyoshi Sakai, Shuitsu Ito, Kazutaka Ito, Daijo Mizumoto, Hirohisa Kato, Shinichi Kumon, Yoshio Haruta, Nobutaka Kudo, Yoshihiko Fukuzawa, Yuzo Watanabe
Publikováno v:
Nephron. 74(1)
Directional atherectomy (DA) was developed as a new therapeutic modality for coronary artery disease. For the past 3 years, we have applied DA intervention to vascular access failure with either poor blood flow rate or high venous pressure. DA interv